Home
April 2008 May 2008 June 2008
Su Mo Tu We Th Fr Sa
Week 18 1 2 3
Week 19 4 5 6 7 8 9 10
Week 20 11 12 13 14 15 16 17
Week 21 18 19 20 21 22 23 24
Week 22 25 26 27 28 29 30 31

Bladder Cancer Diagnosis & Monitoring Center - Current Clinical Trials Show Comments PDF Print E-mail
  
Bladder Cancer Diagnosis and Monitoring Center

Current Clinical Trials

NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-Refractory Patients With Non-Muscle Invasive Bladder Cancer

Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy

Hexvix Cystoscopy for Detection of Bladder Cancer

Combidex USPIO - Ultra-Small Superparamagnetic Iron Oxide

Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

Detection of Bladder Cancer Microsatellite Analysis (MSA) of Urinary Sediment

Survivin Urine mRNA Assay Risk of Bladder Cancer Study

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 1
PoorBest


 
Visitor Ratings:
No Affiliation:
5 (1 votes)